The members of the Board of Management and the Supervisory Board of STRATEC Biomedical AG, as well as persons closely associated with them, shall notify STRATEC Biomedical AG and the Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht, BaFin) of transactions in financial instruments of STRATEC Biomedical AG or derivates of these financial instruments.
All transactions that are subject to disclosure requirements are listed, together with the information required by law (before July 3, 2016 pursuant to section 15a of the German Securities Trading Act (Wertpapierhandelsgesetz, WpHG); from July 3, 2016 pursuant to Art. 19 of the Market Abuse Regulation).
Transactions of the last two years:
| Date and place of transaction | Name and position | Financial instrument and ISIN | Nature of transaction | Price | Aggregated volume | |
|
Jun 22, 2017 |
Claus Vielsack Member of the managing body |
Share DE000STRA555 |
Other Sale of STRATEC shares due to exercising of stock options in STRATEC Biomedical AG. These stock options were granted to the individual in question from the stock option plan in 2012 and 2013 as a variable compensation component. |
58.80 |
176,400.00 |
more… |
|
Jun 22, 2017 |
Robert Siegle Member of the managing body |
Share DE000STRA555 |
Other Sale of STRATEC shares due to exercising of stock options in STRATEC Biomedical AG. These stock options were granted to the individual in question from the stock option plan in 2012 as a variable compensation component. |
58.80 |
735,000.00 |
more… |
|
Jun 22, 2017 |
Marcus Wolfinger Member of the managing body |
Share DE000STRA555 |
Other Sale of STRATEC shares due to exercising of stock options in STRATEC Biomedical AG. These stock options were granted to the individual in question from the stock option plan in 2012 as a variable compensation component. |
58.80 |
735,000.00 |
more… |
|
Jun 22, 2017 |
Claus Vielsack Member of the managing body |
Share DE000STRA555 |
Other Purchase of STRATEC shares due to exercising of stock options in STRATEC Biomedical AG. These stock options were granted to the individual in question from the stock option plan in 2012 and 2013 as a variable compensation component. |
34.74 |
104,230.00 |
more… |
|
Jun 22, 2017 |
Robert Siegle Member of the managing body |
Share DE000STRA555 |
Other Purchase of STRATEC shares due to exercising of stock options in STRATEC Biomedical AG. These stock options were granted to the individual in question from the stock option plan in 2012 as a variable compensation component. |
30.75 |
384,375.00 |
more… |
|
Jun 22, 2017 |
Marcus Wolfinger Member of the managing body |
Share DE000STRA555 |
Other Purchase of STRATEC shares due to exercising of stock options in STRATEC Biomedical AG. These stock options were granted to the individual in question from the stock option plan in 2012 as a variable compensation component. |
30.75 |
384,375.00 |
more… |